Successes & Messes: In DuPont’s Proxy Battle, An Expensive Power Struggle
Submitted by Anonymous (not verified) on
A risky decision to fend off a corporate raider pays off in the end.
Over the past two years, billionaire investor Nelson Peltz and his hedge fund, Trian Fund Management, fought to win up to four seats on DuPont’s 12-person board of directors in the hope of shaking up the 212-year-old company. Over the same two
